HIV pre-exposure prophylaxis (PrEP) and the complexities of biomedical prevention: Ontological openness and the prevention assemblage

HIV Treatment and Prevention Technologies in International Perspective

Volumn , Issue , 2010, Pages 167-183

  Rosengarten, Marsha ^a   Michael, Mike ^a  

^a CITY UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992571542     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1057/9780230297050     Document Type: Chapter

References (28)

1. AVAC (AIDS Vaccine Advocacy Coalition) (2005) Will a Pill a Day Prevent HIV? Anticipating the Results of PREP Trials (New York: AVAC).
2. AVAC (2008) Anticipating the Results of PrEP Trials (New York: AVAC).
3. Barnett, T. and Whiteside, A. (2006) AIDS in the Twenty-First Century: Disease and Globalization (second ed.) (Basingstoke, UK: Palgrave Macmillan).
4. Bass, E. &Kahn, P. (2005) 'Testing AIDS Vaccines in People' AIDS Vaccine Handbook: Global Perspectives (second ed.) (ed.) Patricia Kahn (New York: AIDS Vaccine Advocacy Coalition).
5. Gomart, E. (2004) 'Surprised by Methadone: In Praise of Drug Substitution Treatment in a French Clinic', Body &Society, 10 (2-3): 85-110.
6. Grant, R. M., Buchbinder, S., Cates, W., Clarke, E., Coates, T., Cohen, M. S., Delaney, M., Flores, G., Goicochea, P., Gonsalves, G., Harrington, M., Lama, J. R., MacQueen, K. M., Moore, J. P., Peterson, L., Sanchez, J., Thompson, M., Wainberg, M. A. (2005) 'AIDS: Promote HIV Chemoprophylaxis Research, Don't Prevent It', Science, 30, September: 2170-1.
7. Haraway, D. (1991) Simians, Cyborgs, and Women: The Reinvention of Nature (London: Free Association Books).
8. Jintarkanon, S., Nakapiew, S., Tienudom, N., Suwannawong, P. and Wilson, D. (2005) 'Unethical Clinical Trials in Thailand: A Community Response', Lancet, 365: 1617-18.
9. Kippax, S. (2005) 'Pre-Exposure Prophylaxis (PREP)', PREP Forum, Cockle Bay, Australia, 16 June.
10. Kippax, S., and K. Race (2003) 'Sustaining Safe Practice: Twenty Years On', Social Science &Medicine, 57: 1-12.
11. MacQueen, K. M., Namey, E., Chilongozi, D. A., Mtweve, S. P., Mlingo, M., Morar, N., Reid, C., Ristow, A., Sahay, S., HPTN 035 Standard Of Care Assessment Team (2007) 'Community Perspectives on Care Options for HIV Prevention Trial Participants', AIDS Care, 19 (4): 554-60.
12. Michael, M. (2006) Technoscience and Everyday Life: The Complex Simplicities of the Mundane (UK: Open University Press).
13. Mills, E., Rachlis, B., Wu, P., Wong, E., Wilson, K. and Singh, S. (2005) 'Media Reporting of Tenofovir Trials in Cambodia and Cameroon', BMC International Health and Human Rights, 5 (6): 1-7.
14. Mills, E., Nixon, S., Singh, S., Dolma, S., Nayyar, A. and Kapoor, S. (2006) 'Enrolling Women into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge', PLoS Medicine, March, 3 (3, e94): 1-4.
15. Mol, A. (2003) The Body Multiple: Ontology in Medical Practice (Durham: Duke University Press).
16. Mol, A. and Law, J. (2004) 'Embodied Action, Enacted Bodies: The example of Hypoglycaemia', Body &Society, 10 (2-3): 43-62.
17. Page-Shafer, K., Saphonn, V., Penh Sun, L., Chhi Vun, M., Cooper, D. A. and Kaldor, J. M. (2005) 'HIV Prevention Research in a Resource-limited Setting: The Experience of Planning a Trial in Cambodia', The Lancet, 366: 1499-503.
18. Paxton, L. A., Hope, T. and Jaffe, H. W. (2007) 'Pre-exposure Prophylaxis for HIV Infection: What if it works?', Lancet, 370: 89-93.
19. Potts, A. (2004) 'Deleuze on Viagra (Or, What Can a 'Viagra-body' Do?)', Body &Society, 10 (1): 17-36.
20. Rosengarten, M. (2009) HIV Interventions: Biomedicine and the Traffic in Information and Flesh (Seattle/London: University of Washington Press).
21. Rosengarten, M. and Michael, M. (2009a) 'Rethinking the Bioethical Enactment of Drugged Bodies: On the Paradoxes of using anti-HIV Drug Therapy as a Technology for Prevention', Special Issue on 'Drugged Bodies', Science as Culture, Guest editors: Suzanne Fraser, Celia Roberts and Kylie Valentine, 18 (2): 183-99.
22. Rosengarten, M. and Michael, M. (2009b) 'The performative function of expectations in translating treatment to prevention: the case of HIV pre-exposure prophylaxis or PrEP', Social Science and Medicine, 69 (7): 1049-55.
23. Singh, J. A. and Mills, E. J. (2005) 'The Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong?', PLoS Medicine, 2 (9, e234): 0001-4.
24. The Thai AIDS Treatment Action Group TTATAG (2004) Letter 8 December, available at: http://www.aidsinfonyc.org/tag/activism/thaiTenofovir.html.
25. Treichler, P. (1999) How to Have Theory in an Epidemic: Cultural Chronicles of AIDS (Durham, NC: Duke University Press).
26. WHO/UNAIDS (2004) 'Treating People with Intercurrent Infection in HIV Prevention Trials, Report from a WHO/UNAIDS consultation, Geneva 17-18 July 2003 p. 1', AIDS, 21 (18, 15): W1-12.
27. UNAIDS/WHO (2007) Press Release. Available at: http://data.unaids.org/pub/ EPISlides/2007/071119_epi_pressrelease_en.pdf.
28. Venn, C. (2006) 'A Note on Assemblage', Theory, Culture &Society, 23, (2-3): 107-8.